Catalyst Wire Dossier Catalyst Wire Dossier

13-valent pneumococcal conjugate vaccine (PCV13) with DTaP

13-valent pneumococcal conjugate vaccine · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 13-valent pneumococcal conjugate vaccine (PCV13) with DTaP, covering 2012-10-12 to 2012-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants [Phase 3]

See pricing